Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaSurvival RateLeukemia, Myeloid, AcuteTreatment OutcomeLeukemia, B-CellPrognosisSurvival AnalysisAsparaginaseCell SurvivalLeukemic InfiltrationLeukemia, T-CellLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVidarabineMethotrexatePrecursor B-Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesLeukemia, Biphenotypic, AcuteVincristineAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsBone MarrowRemission InductionRemission, SpontaneousCytarabineRetrospective StudiesGene Expression Regulation, LeukemicLymphocytes, NullDisease-Free SurvivalTime Factors6-MercaptopurineImmunoglobulin Heavy ChainsLeukemia, ExperimentalLeukemia-Lymphoma, Adult T-CellLymphomaRecurrenceReceptors, Antigen, B-CellBurkitt LymphomaZAP-70 Protein-Tyrosine KinaseChlorambucilFollow-Up StudiesLeukemia, Hairy CellCyclophosphamideDNA, NeoplasmRosette FormationKaryotypingPhiladelphia ChromosomeChromosomes, Human, 6-12 and XAnisocoriaAcute DiseaseKaplan-Meier EstimateAntibodies, MonoclonalLymphocytesCorneal PerforationTumor Cells, CulturedChromosome AberrationsAntigens, NeoplasmBlast CrisisRisk FactorsLeukemia Virus, MurineT-LymphocytesTranslocation, GeneticPrednisoneCladribineDrug Resistance, NeoplasmNeoplasm StagingLeukemia, MyeloidOutcome Assessment (Health Care)Antigens, CD5ApoptosisGraft SurvivalFusion Proteins, bcr-ablNeoplasm ProteinsMutationSurvivalDNA NucleotidylexotransferaseAntigens, CD38Bone Marrow TransplantationDrug Administration ScheduleFlow CytometryImmunoglobulin Variable RegionSalvage TherapyDaunorubicinDoxorubicinChromosomes, Human, Pair 14Combined Modality TherapyNeprilysinCell Line, TumorBase SequenceTransplantation, HomologousAntibodies, Monoclonal, Murine-DerivedAntigens, SurfaceMolecular Sequence DataClinical Trials as TopicDexamethasonePolymerase Chain ReactionTumor Markers, BiologicalProportional Hazards Models